Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1s have been approved for diabetes for two decades, but more recent iterations of the drugs have shown strong efficacy in promoting weight loss and helping with related conditions, like heart disease and sleep apnea
Future Applications There are many other conditions that may be treated by AOM as set out below
This guide explains exactly what separates them, what the clinical evidence shows, and what your actual options are if brand-name pricing or availability is a barrier
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) were developed for type 2 diabetes but are now widely prescribed for weight loss
Plus, the balanced, hypoallergenic recipe makes it a fantastic choice for individuals who suffer from occasional body acne breakouts
